Mortality rate, under-5, male (per 1,000 live births)

Under-five mortality rate, male is the probability per 1,000 that a newborn male baby will die before reaching age five, if subject to male age-specific mortality rates of the specified year.


Under-5 mortality rate (per 1,000 live births): Q1 (lowest)

Health Nutrition and Population Statistics by Wealth Quintile

Under-5 mortality rate: Number of deaths to children under age five years per 1000 live births, based on experience during the reference period before the survey. The reference period is ten years preceding the survey for DHS surveys, and the reference period varies for MICS surveys (often three to five years preceding the survey).


Under-5 mortality rate (per 1,000 live births): Q2


Under-5 mortality rate (per 1,000 live births): Q3


Under-5 mortality rate (per 1,000 live births): Q4


Under-5 mortality rate (per 1,000 live births): Q5 (highest)


Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%)

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes,  or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).

World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).


Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)


Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%)


Mortality rate, neonatal (per 1,000 live births)

Neonatal mortality rate is the number of neonates dying before reaching 28 days of age, per 1,000 live births in a given year.

Estimates developed by the UN Inter-agency Group for Child Mortality Estimation (UNICEF, WHO, World Bank, UN DESA Population Division) at www.childmortality.org.


Stillbirth rate (per 1,000 total births)

Health Nutrition and Population Statistics

Stillbirth rate is the number of fetal deaths at 28 weeks or more of gestation per 1,000 total births. Total birth is the sum of stillbirths (as just defined) and live births.


Acceptability of media messages on family planning (% of women): Q1 (lowest)

Acceptability of media messages on family planning: Percentage of all women who believe that it is acceptable to have messages about family planning on the radio or television.


Acceptability of media messages on family planning (% of women): Q2


Acceptability of media messages on family planning (% of women): Q3


Acceptability of media messages on family planning (% of women): Q4


Acceptability of media messages on family planning (% of women): Q5 (highest)


Median age at first birth (women ages 25-49): Q1 (lowest)

Median age at first birth: Median age at first birth among women aged 25-49 years.


Median age at first birth (women ages 25-49): Q2


Median age at first birth (women ages 25-49): Q3


Median age at first birth (women ages 25-49): Q4


Median age at first birth (women ages 25-49): Q5 (highest)


Median age at first marriage (women ages 25-49): Q1 (lowest)

Median age at first marriage: Median age at first marriage among women aged 25-49 years.


Median age at first marriage (women ages 25-49): Q2


Median age at first marriage (women ages 25-49): Q3


Median age at first marriage (women ages 25-49): Q4


Median age at first marriage (women ages 25-49): Q5 (highest)


Median age at first sexual intercourse (women ages 25-49): Q1 (lowest)

Median age at first sexual intercourse: Median age at first sexual intercourse among women aged 25-49 years.


Median age at first sexual intercourse (women ages 25-49): Q2


Median age at first sexual intercourse (women ages 25-49): Q3


Median age at first sexual intercourse (women ages 25-49): Q4


Median age at first sexual intercourse (women ages 25-49): Q5 (highest)


Heard family planning on radio and television (% of women): Q1 (lowest)

Heard family planning on radio and television: Percentage of all women who have heard a radio or television message about family planning in the last few months prior to the interview.


Heard family planning on radio and television (% of women): Q2


Heard family planning on radio and television (% of women): Q3


Heard family planning on radio and television (% of women): Q4


Heard family planning on radio and television (% of women): Q5 (highest)


Mean ideal number of children (per woman): Q1 (lowest)

Mean ideal number of children: Mean ideal number of children for all women.


Mean ideal number of children (per woman): Q2


Mean ideal number of children (per woman): Q3


Mean ideal number of children (per woman): Q4


Mean ideal number of children (per woman): Q5 (highest)


Knowledge of any modern method of contraception (% of all women ages 15-49)

Percentage of all women ages 15-49 who know at least one of modern methods of contraception. Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception.

Demographic and Health Surveys (DHS) (https://www.statcompiler.com/)


Knowledge of any modern method of contraception  (% of all men)

Percentage of all men who know at least one of modern methods of contraception. Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception. The age range of men depends on surveys.  In most DHS surveys, men ages 15-49, 15-54, or 15-59 are eligible for individual interviews.


Knowledge of any modern method of contraception (% of married women ages 15-49)

Percentage of currently married or in union women ages 15-49 who know at least one of modern methods of contraception. Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception.


Knowledge of any modern method of contraception  (% of married men)

Percentage of currently married or in union men who know at least one of modern methods of contraception. Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception. In most DHS surveys, men ages 15-49, 15-54, or 15-59 are eligible for individual interviews.


Knowledge of any method of contraception (% of all women ages 15-49)

Percentage of all women ages 15-49 who know any method of contraception.  Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception. Traditional methods includes periodic abstinence (rhythm, calendar method) and withdrawal.


Knowledge of any method of contraception (% of all men)

Percentage of all men who know any method of contraception. Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception. Traditional methods includes periodic abstinence (rhythm, calendar method) and withdrawal.  The age range of men depends on surveys.  In most DHS surveys, men ages 15-49, 15-54, or 15-59 are eligible for individual interviews.


Knowledge of any method of contraception (% of married women ages 15-49)

Percentage of currently married or in union women ages 15-49 who know any method of contraception. Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception. Traditional methods includes periodic abstinence (rhythm, calendar method) and withdrawal.


Knowledge of any method of contraception (% of married men)

Percentage of currently married or in union men who know any method of contraception.  Modern methods of contraception include female and male sterilization, contraceptive pills, intra-uterine device (IUD), injectables, implants, male and female condoms, diaphragm, contraceptive foam and contraceptive jelly female condom, lactational amenorrhea method (LAM), Standard days method (SDM), and emergency contraception. Traditional methods includes periodic abstinence (rhythm, calendar method) and withdrawal.  The age range of men depends on surveys.  In most DHS surveys, men ages 15-49, 15-54, or 15-59 are eligible for individual interviews.


Knowledge of contraception (any method) (% of married women): Q1 (lowest)

Knowledge of contraception: Percentage of currently married women who know at least one contraceptive method and at least one modern contraceptive method.


Knowledge of contraception (any method) (% of married women): Q2


Knowledge of contraception (any method) (% of married women): Q3


Knowledge of contraception (any method) (% of married women): Q4


Knowledge of contraception (any method) (% of married women): Q5 (highest)


Knowledge of contraception (modern method) (% of married women): Q1 (lowest)


Knowledge of contraception (modern method) (% of married women): Q2


Knowledge of contraception (modern method) (% of married women): Q3


Knowledge of contraception (modern method) (% of married women): Q4


Knowledge of contraception (modern method) (% of married women): Q5 (highest)


Desire to stop (limit) childbearing (% of married women): Q1 (lowest)

Desire to stop (limit) childbearing: Percentage of currently married women who want no more children. Women who have been sterilized or whose spouses are sterilized, are considered to want no more children.


Desire to stop (limit) childbearing (% of married women): Q2


Desire to stop (limit) childbearing (% of married women): Q3


Desire to stop (limit) childbearing (% of married women): Q4


Desire to stop (limit) childbearing (% of married women): Q5 (highest)


Median birth interval (months): Q1 (lowest)

Median birth interval: Median duration of the birth interval in months for non-first births in the five years preceding the survey.


Median birth interval (months): Q5 (highest)


Fertility planning status (wanted later) (% of births): Q1 (lowest)

Fertility planning status: Percentage of births in the five years preceding the survey which are planned (wanted then), mistimed (wanted later), and unplanned (wanted no more).


Fertility planning status (wanted later) (% of births): Q2


Fertility planning status (wanted later) (% of births): Q3


Fertility planning status (wanted later) (% of births): Q4


Fertility planning status (wanted later) (% of births): Q5 (highest)


Fertility planning status: mistimed pregnancy (% of births)

The proportion of women ages 15-49 who reported the last birth in the five years preceding the survery was mistimed (wanted later).


Family planning messages in print (% of women): Q1 (lowest)

Family planning messages in print: Percentage of all women who have received a message about family planning from printed media in the last few months prior to the interview.


Family planning messages in print (% of women): Q2


Family planning messages in print (% of women): Q3


Family planning messages in print (% of women): Q4


Family planning messages in print (% of women): Q5 (highest)


Demand for family planning satisfied by any methods (% of married women with demand for family planning)

Demand for family planning satisfied by any methods refers to the percentage of married women ages 15-49 whose need for family planning is satisfied.


Demand for family planning satisfied by modern methods (% of married women with demand for family planning)

Demand for family planning satisfied by modern methods refers to the percentage of married women ages 15-49 years whose need for family planning is satisfied with modern methods.


Fertility planning status (wanted no more) (% of births): Q1 (lowest)


Fertility planning status (wanted no more) (% of births): Q2


Fertility planning status (wanted no more) (% of births): Q3


Fertility planning status (wanted no more) (% of births): Q4


Fertility planning status (wanted no more) (% of births): Q5 (highest)


Fertility planning status: unwanted pregnancy (% of births)

The proportion of women ages 15-49 who reported the last birth in the five years preceding the survery was unwanted.


Fertility planning status (wanted then) (% of births): Q1 (lowest)


Fertility planning status (wanted then) (% of births): Q2


Fertility planning status (wanted then) (% of births): Q3


Fertility planning status (wanted then) (% of births): Q4


Fertility planning status (wanted then) (% of births): Q5 (highest)


Fertility planning status: planned pregnancy (% of births)

The proportion of women ages 15-49 who reported the last birth in the five years preceding the survery was planned (wanted then).


People using at least basic drinking water services (% of population): Q1 (lowest)

WHO/UNICEF Joint Monitoring Programme (JMP) for Water Supply, Sanitation and Hygiene (washdata.org).


People using at least basic drinking water services (% of population): Q2


People using at least basic drinking water services (% of population): Q3


People using at least basic drinking water services (% of population): Q4


People using at least basic drinking water services (% of population): Q5 (highest)


People using at least basic drinking water services, rural (% of rural population): Q1 (lowest)


People using at least basic drinking water services, rural (% of rural population): Q2


People using at least basic drinking water services, rural (% of rural population): Q3


People using at least basic drinking water services, rural (% of rural population): Q4


People using at least basic drinking water services, rural (% of rural population): Q5 (highest)


People using at least basic drinking water services, rural (% of rural population)

The percentage of people using at least basic water services.  This indicator encompasses both people using basic water services as well as those using safely managed water services.  Basic drinking water services is defined as drinking water from an improved source, provided collection time is not more than 30 minutes for a round trip.  Improved water sources include piped water, boreholes or tubewells, protected dug wells, protected springs, and packaged or delivered water.


People using at least basic drinking water services, urban (% of urban population): Q1 (lowest)


People using at least basic drinking water services, urban (% of urban population): Q2


People using at least basic drinking water services, urban (% of urban population): Q3


People using at least basic drinking water services, urban (% of urban population): Q4


People using at least basic drinking water services, urban (% of urban population): Q5 (highest)


People using at least basic drinking water services, urban (% of urban population)


People using at least basic drinking water services (% of population)


Improved water source, rural (% of rural population with access)

Access to an improved water source, rural, refers to the percentage of the rural population using an improved drinking water source. The improved drinking water source includes piped water on premises (piped household water connection located inside the user’s dwelling, plot or yard), and other improved drinking water sources (public taps or standpipes, tube wells or boreholes, protected dug wells, protected springs, and rainwater collection).

WHO/UNICEF Joint Monitoring Programme (JMP) for Water Supply and Sanitation (http://www.wssinfo.org/).


Improved water source, urban (% of urban population with access)

Access to an improved water source, urban, refers to the percentage of the urban population using an improved drinking water source. The improved drinking water source includes piped water on premises (piped household water connection located inside the user’s dwelling, plot or yard), and other improved drinking water sources (public taps or standpipes, tube wells or boreholes, protected dug wells, protected springs, and rainwater collection).


Improved water source (% of population with access)

Access to an improved water source refers to the percentage of the population using an improved drinking water source. The improved drinking water source includes piped water on premises (piped household water connection located inside the user’s dwelling, plot or yard), and other improved drinking water sources (public taps or standpipes, tube wells or boreholes, protected dug wells, protected springs, and rainwater collection).


People using safely managed drinking water services, rural (% of rural population)

The percentage of people using drinking water from an improved source that is accessible on premises, available when needed and free from faecal and priority chemical contamination. Improved water sources include piped water, boreholes or tubewells, protected dug wells, protected springs, and packaged or delivered water.


People using safely managed drinking water services, urban (% of urban population)


People using safely managed drinking water services (% of population)


Children (0-14) living with HIV

Children living with HIV refers to the number of children ages 0-14 who are infected with HIV.


Prevalence of HIV, young women 15-24 years (%; high estimate)

Prevalence of HIV, female refers to the percentage of females ages 15-24 who are infected with HIV based the high estimate.

UNAIDS and the WHO's Report on the Global AIDS Epidemic.


Prevalence of HIV, young women 15-24 years (%; low estimate)

Prevalence of HIV, female refers to the percentage of females ages 15-24 who are infected with HIV based the low estimate.


Prevalence of HIV, female (% ages 15-24)

Prevalence of HIV, female is the percentage of females who are infected with HIV. Youth rates are as a percentage of the relevant age group.


Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)

The percent of female respondents ages 15-24 who correctly identify the two major ways of preventing the sexual transmission of HIV (using condoms and limiting sex to one faithful, uninfected partner), who reject the two most common local misconceptions about HIV transmission, and who know that a healthy-looking person can have HIV.

Household surveys such as Demographic and Health Surveys and Multiple Indicator Cluster Surveys.  Largely compiled by UNICEF.


Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)

The percent of male respondents ages 15-24 who correctly identify the two major ways of preventing the sexual transmission of HIV (using condoms and limiting sex to one faithful, uninfected partner), who reject the two most common local misconceptions about HIV transmission, and who know that a healthy-looking person can have HIV.


Prevalence of HIV, young men 15-24 years (%; high estimate)

Prevalence of HIV, male refers to the percentage of females ages 15-24 who are infected with HIV based the high estimate.


Prevalence of HIV, young men 15-24 years (%; low estimate)

Prevalence of HIV, male refers to the percentage of females ages 15-24 who are infected with HIV based the low estimate.


Prevalence of HIV, male (% ages 15-24)

Prevalence of HIV, male is the percentage of males who are infected with HIV. Youth rates are as a percentage of the relevant age group.


Access to anti-retroviral drugs, female (%)

The percentage of adult females living with HIV who are receiving antiretroviral therapy.


Access to anti-retroviral drugs, male (%)

The percentage of adult males living with HIV who are receiving antiretroviral therapy.


Antiretroviral therapy coverage (% of people living with HIV)

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.


AIDS deaths in adults and children (high estimate)

Deaths due to HIV/AIDS are the estimated number of adults and children that have died in a specific year based in the modeling of HIV surveillance data using standard and appropriate tools.


AIDS deaths in adults and children (low estimate)


Adults (ages 15-49) newly infected with HIV

Number of adults (ages 15-49) newly infected with HIV.


Children (ages 0-14) newly infected with HIV

Number of children (ages 0-14) newly infected with HIV.


Incidence of HIV, ages 50+ (per 1,000 uninfected population ages 50+)

Number of new HIV infections among uninfected populations ages 50+ expressed per 1,000 uninfected population ages 50+ in the year before the period.


Incidence of HIV, ages 15-49, female (per 1,000 uninfected female population ages 15-49)

Number of new HIV infections among uninfected female populations ages 15-49 expressed per 1,000 uninfected female population ages 15-49 in the year before the period.


Incidence of HIV, ages 15-49, male (per 1,000 uninfected male population ages 15-49)

Number of new HIV infections among uninfected male populations ages 15-49 expressed per 1,000 uninfected male population ages 15-49 in the year before the period.


Adults (ages 15+) and children (ages 0-14) newly infected with HIV

Number of adults (ages 15+) and children (ages 0-14) newly infected with HIV.


Incidence of HIV, all (per 1,000 uninfected population)

Number of new HIV infections among uninfected populations expressed per 1,000 uninfected population in the year before the period.


Young people (ages 15-24) newly infected with HIV

Number of young people (ages 15-24) newly infected with HIV.


Incidence of HIV, ages 15-24, female (per 1,000 uninfected female population ages 15-24)

Number of new HIV infections among uninfected male populations ages 15-24 expressed per 1,000 uninfected male population ages 15-24 in the year before the period.


Incidence of HIV, ages 15-24, male (per 1,000 uninfected male population ages 15-24)

Number of new HIV infections among uninfected female populations ages 15-24 expressed per 1,000 uninfected female population ages 15-24 in the year before the period.


Incidence of HIV, ages 15-24 (per 1,000 uninfected population ages 15-24)

Number of new HIV infections among uninfected populations ages 15-24 expressed per 1,000 uninfected population ages 15-24 in the year before the period.


Incidence of HIV, ages 15-49 (per 1,000 uninfected population ages 15-49)

Number of new HIV infections among uninfected populations ages 15-49 expressed per 1,000 uninfected population in the year before the period.


Comprehensive correct knowledge of HIV/AIDS, ages 15-49, female (2 prevent ways and reject 3 misconceptions)

Knowledge of HIV, female, is the percentage of female respondents who correctly identify the two major ways of preventing the sexual transmission of HIV (using condoms and limiting sex to one faithful, uninfected partner), who reject the two most common local misconceptions about HIV transmission, and who know that a healthy-looking person can have HIV.


Comprehensive correct knowledge of HIV/AIDS, ages 15-49, male (2 prevent ways and reject 3 misconceptions)

Knowledge of HIV, male, is the percentage of male respondents who correctly identify the two major ways of preventing the sexual transmission of HIV (using condoms and limiting sex to one faithful, uninfected partner), who reject the two most common local misconceptions about HIV transmission, and who know that a healthy-looking person can have HIV.


New HIV infections (0-14 years), high estimate

Estimated number of children (0-14 years) newly infected with HIV, high estimate.


New HIV infections (0-14 years), low estimate

Estimated number of children (0-14 years) newly infected with HIV, low estimate.


New HIV infections (0-14 years)

Estimated number of children (0-14 years) newly infected with HIV.


New HIV infections, high estimate

Estimated number of people newly infected with HIV, high estimate.


New HIV infections, low estimate

Estimated number of people newly infected with HIV, low estimate.


New HIV infections

Estimated number of people newly infected with HIV.


Orphans 0-17 years currently living (high estimate)

AIDS orphans are the estimated number of children who have lost their mother or both parents to AIDS before age 17 since the epidemic began in 1990. Some of the orphaned children included in this cumulative total are no longer alive; others are no longer under age 17.


Orphans 0-17 years currently living (low estimate)


Children orphaned by HIV/AIDS

Number of children orphaned by HIV/AIDS is the estimated number of children who have lost their mother or both parents to AIDS before age 15 since the epidemic began. Some of the orphaned children included in this cumulative total are no longer alive; others are no longer under age 15.


Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).


HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate)

Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission.  Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission.  Denominator: Estimated number of HIV-infected pregnant women in the last 12 months.  Ranges are presented for countries with low and concentrated epidemics.  The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.  All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted.  All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum).  The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.


HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; low estimate)


Number of HIV positive pregnant women receiving antiretrovirals

Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission.  The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.


HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%)

Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission.  Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission.  Denominator: Estimated number of HIV-infected pregnant women in the last 12 months.  The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.  All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted.  All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum).  The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.


Adults (ages 15+) and children (0-14 years) living with HIV

Adults and children living with HIV refers to the number of people ages 0-49 (adult ages 15-49 and children ages 0-14) who are infected with HIV.


People living with HIV/AIDS, total (high estimate)

Estimated total number of people with HIV/AIDS is the number of people living with HIV. Depending on the reliability of the data available, there may be more or less uncertainty surrounding each estimate.


People living with HIV/AIDS, total (low estimate)


Number of hospitals

Indonesia Database for Policy and Economic Research

BADAN PUSAT STATISTIK - Statistics Indonesia, Village Census (PODES)


Prevalence of hypertension, female (% of female adults ages 30-79)

Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension).	The data is age-standardized.

World Health Organization's Global Health Observatory Data Repository


Prevalence of hypertension, male (% of male adults ages 30-79)

Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension).	The data is age-standardized.


Prevalence of hypertension (% of adults ages 30-79)

Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension).	The data is age-standardized.


Treatment for hypertension, female (% of female adults ages 30-79 with hypertension)

Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension.  Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.


Treatment for hypertension, male (% of male adults ages 30-79 with hypertension)

Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension.  Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.


Treatment for hypertension (% of adults ages 30-79 with hypertension)


Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)

Vaccinations: Percentage of children 12-23 months who have received specific vaccines by the time of the survey (according to the vaccination card or the mother's report). Children with all vaccinations refer children who have received BCG, measles, and three doses each of DPT and polio vaccine (excluding polio 0). Some MICS surveys refer children in different age groups (e.g. 18-29 months, or 15-26 months).


Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2


Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3


Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4


Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)


Immunization Coverage for Children under 5 years old (in % of children population under 5 years old)

Immunization is the process whereby weakened bacteria is injected or taken orally for the purpose of developing an immunity towards a particular disease.

BADAN PUSAT STATISTIK - Statistics Indonesia, National Social Economic Survey (SUSENAS)


Immunization, HepB3 (% of one-year-old children)

Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).


Immunization, Hib3 (% of children ages 12-23 months)

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.


Immunization, BCG (% of one-year-old children)

Child immunization rate, BCG is the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey for BCG. A child is considered adequately immunized after one dose.


Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)


Vaccinations (BCG) (% of children ages 12-23 months): Q2


Vaccinations (BCG) (% of children ages 12-23 months): Q3


Vaccinations (BCG) (% of children ages 12-23 months): Q4


Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)


Immunization, DPT (% of children ages 12-23 months)

Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.


Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)


Vaccinations (DPT 3) (% of children ages 12-23 months): Q2


Vaccinations (DPT 3) (% of children ages 12-23 months): Q3


Vaccinations (DPT 3) (% of children ages 12-23 months): Q4


Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)


Immunization, measles second dose (% of children by the nationally recommended age)

Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.


Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.


Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)


Vaccinations (Measles) (% of children ages 12-23 months): Q2


Vaccinations (Measles) (% of children ages 12-23 months): Q3


Vaccinations (Measles) (% of children ages 12-23 months): Q4


Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)


Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)


Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2


Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3


Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4


Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)


Immunization, Pol3 (% of one-year-old children)

Child immunization rate, polio, is the percentage of children ages 12-23 months who received polio vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.


Hospital beds (per 1,000 people)

Hospital beds include inpatient beds available in public, private, general, and specialized hospitals and rehabilitation centers. In most cases beds for both acute and chronic care are included.

Data are from the World Health Organization, supplemented by country data.


Community health workers (per 1,000 people)

Community health workers include various types of community health aides, many with country-specific occupational titles such as community health officers, community health-education workers, family health workers, lady health visitors and health extension package workers.

World Health Organization's Global Health Workforce Statistics, OECD, supplemented by country data.


Nurses and midwives (per 1,000 people)

Nurses and midwives include professional nurses, professional midwives, auxiliary nurses, auxiliary midwives, enrolled nurses, enrolled midwives and other associated personnel, such as dental nurses and primary care nurses.


Physicians (per 1,000 people)

Physicians include generalist and specialist medical practitioners.


Specialist surgical workforce (per 100,000 population)

Specialist surgical workforce is the number of specialist surgical, anaesthetic, and obstetric (SAO) providers who are working in each country per 100,000 population.

Data collected by the Lancet Commission on Global Surgery (www.lancetglobalsurgery.org); Data collected by WHO Collaborating Centre for Surgery and Public Health at Lund University from various sources including Ministries of Health or equivalent national regulatory bodies, national official entities such as medical councils, Eurostat, OECD, WHO Euro Health For All Database, WHO EURO Technical resources for health Database; BMJ Glob Health.


Reported clinical malaria cases (total)

Number of clinical malaria cases reported are the sum of cases confirmed by slide examination or RDT and probable and unconfirmed cases (cases that were not tested but treated as malaria). NMCPs often collect data on the number of suspected cases, those t

World Health Organization Global Malaria Programme (http://www.who.int/malaria/world_malaria_report_2009/all_mal2009_annexes.pdf)


Deaths among children under five years of age due to malaria (%)

"Malaria mortality is the percentage of deaths due to malaria among children under five years.  Malaria was the underlying cause of death, that is, the disease which initiated the train of morbid events leading directly to death. This is the distribution of main causes of death among children aged < 5 years, expressed as percentage of total deaths.
 "


Reported malaria deaths (total)

Reported malaria deaths include all deaths in health facilities that are attributed to malaria, whether or not confirmed by microscopy or by RDT.   Deaths reported before 2000 can be probable and confirmed or only confirmed deaths depending on the country


Notified cases of malaria (per 100,000 people)

Malaria incidence is expressed as the number of new cases of malaria per 100,000 people each year. The number of cases reported is adjusted to take into account incompleteness in reporting systems, patients seeking treatment in the private sector, self-medicating or not seeking treatment at all, and potential over-diagnosis through the lack of laboratory confirmation of cases.


Incidence of malaria (per 1,000 population at risk)

Incidence of malaria is the number of new cases of malaria in a year per 1,000 population at risk.

World Health Organization, World malaria report and Global Health Observatory Data Repository/World Health Statistics (http://apps.who.int/ghodata/).


Intermittent preventive treatment (IPT) of malaria in pregnancy (% of pregnant women)

Percentage of women aged 15 - 49 with a live birth in the recent years preceding the survey who received 3+ doses of sulfadoxine-pyrimethamine (SP/Fansidar), at least one during an antenatal care visit. Intermittent Preventive Treatment (IPT) is preventive treatment with SP/Fansidar during an antenatal care (ANC) visit treatment with a dose of sulfadoxine-pyrimethamine (SP/Fansidar) to pregnant women at each scheduled antenatal visit after the first trimester, but not more frequently than once a month.

UNICEF Global Databases [data.unicef.org], Multiple Indicator Cluster Surveys, Demographic and Health Surveys.


Households with one or more insect-treated mosquito net (%)

Percentage of households owning at least one insecticide-treated bednet (ITN).


Mosquito net use by children (any mosquito net) (% of children under 5): Q1 (lowest)

Mosquito net use by children: Percentage of children under age five years who slept under any mosquito net (treated or untreated), and an insecticide-treated net (ITN) the night before the survey.


Mosquito net use by children (any mosquito net) (% of children under 5): Q2


Mosquito net use by children (any mosquito net) (% of children under 5): Q3


Mosquito net use by children (any mosquito net) (% of children under 5): Q4


Mosquito net use by children (any mosquito net) (% of children under 5): Q5 (highest)


Household posession of mosquito nets (any type of mosquito net) (% of households): Q1 (lowest)

Household possession of mosquito nets: Percentage of households with at least one any type of mosquito net (treated or untreated), and insecticide-treated net (ITN).


Household posession of mosquito nets (any type of mosquito net) (% of households): Q2


Household posession of mosquito nets (any type of mosquito net) (% of households): Q3


Household posession of mosquito nets (any type of mosquito net) (% of households): Q4


Household posession of mosquito nets (any type of mosquito net) (% of households): Q5 (highest)


Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q1 (lowest)

Mosquito net use by pregnant women: Percentage of pregnant women who slept under any mosquito net (treated or untreated), and an insecticide-treated net (ITN) the night before the survey.


Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q2


Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q3


Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q4


Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q5 (highest)


Malaria prevention, use of bed nets (% of under-5 children in the poorest quintile)

Use of bed nets by children in the poorest quintile refers to the percentage of children under age five in the poorest quintile who slept under an any type of mosquito bednet to prevent malaria.

Demographic and Health Surveys by Macro International.


Mosquito net use by children (insecticide-treated net) (% of children under 5): Q2


Mosquito net use by children (insecticide-treated net) (% of children under 5): Q3


Mosquito net use by children (insecticide-treated net) (% of children under 5): Q4


Malaria prevention, use of bed nets (% of under-5 children in the richest quintile)

Use of bed nets by children in the richest quintile refers to the percentage of children under age five in the richest quintile who slept under an any type of mosquito bednet to prevent malaria.


Use of insecticide-treated bed nets (% of under-5 population)

Use of insecticide-treated bed nets refers to the percentage of children under age five who slept under an insecticide-treated bednet to prevent malaria.

UNICEF, State of the World's Children, Childinfo, and Demographic and Health Surveys.


Household posession of mosquito nets (insecticide-treated net) (% of households): Q1 (lowest)


Household posession of mosquito nets (insecticide-treated net) (% of households): Q2


Household posession of mosquito nets (insecticide-treated net) (% of households): Q3


Household posession of mosquito nets (insecticide-treated net) (% of households): Q4


Household posession of mosquito nets (insecticide-treated net) (% of households): Q5 (highest)


Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q1 (lowest)


Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q2


Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q3


Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q4


Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q5 (highest)


Pregnant women who took at least 2 doses of intermittent preventative treatment (%)

Percentage of pregnant women reporting to have received IPT (intermittent preventive treatment; 2 or more doses).


Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q1 (lowest)

Anti-malarial drug use by pregnant women: Percentage of women with a live birth in the two years preceding the survey who during the pregnancy took any antimalarial drug for prevention, and who took SP/Fansidar two or more doses.


Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q2


Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q3


Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4


Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q5 (highest)


Treatment of fever (% of children under 5 with fever): Q1 (lowest)

Treatment of fever: Percentage of children under age five years with fever in the two weeks preceding the survey who took antimalarial drugs.


Treatment of fever (% of children under 5 with fever): Q2


Treatment of fever (% of children under 5 with fever): Q3


Treatment of fever (% of children under 5 with fever): Q4


Treatment of fever (% of children under 5 with fever): Q5 (highest)


Children with fever receiving antimalarial drugs (% of children under age 5 with fever)

Malaria treatment refers to the percentage of children under age five who were ill with fever in the last two weeks and received any appropriate (locally defined) anti-malarial drugs.


Number of maternal deaths

A maternal death refers to the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes.

WHO, UNICEF, UNFPA, World Bank Group, and UNDESA/Population Division. Trends in Maternal Mortality 2000 to 2020. Geneva, World Health Organization, 2023


Length of paid maternity leave (calendar days)

The indicator refers to leave available only to the mother for the birth of a child to be taken just before, during and immediately after childbirth.

World Bank: Women, Business and the Law. https://wbl.worldbank.org/


Paid leave of at least 14 weeks available to mothers (1=yes; 0=no)

The indicator measures  whether women are legally entitled to at least 14 weeks (98 calendar days) of paid leave for the birth of a child through maternity leave, parental leave or a combination of both.


The government administers 100 percent of maternity leave benefits (1=yes; 0=no)

The indicator measures whether leave benefits are fully administered by a government entity, including compulsory social insurance schemes (such as social security), public funds, government-mandated private insurance or employer reimbursement of any maternity leave benefits paid directly to an employee.


Lifetime risk of maternal death (1 in: rate varies by country)

Life time risk of maternal death is the probability that a 15-year-old female will die eventually from a maternal cause assuming that current levels of fertility and mortality (including maternal mortality) do not change in the future, taking into account competing causes of death.


Maternal leave benefits (% of wages paid in covered period)

Maternity leave benefits refers to the total percentage of wages covered by all sources during paid maternity leave.

World Bank, Women, Business and the Law.


Length of paid shared parental leave (calendar days)

The indicator refers to parental leave that can be shared amongst the parents as they choose. Parental leave refers to leave available equally to parents—regardless of gender—for the purpose of childcare immediately following maternity and paternity leave OR instead of maternity and paternity leave.


There is paid parental leave (1=yes; 0=no)

The indicator measures whether both parents are legally entitled to some form of full-time paid parental leave either shared between mother and father or as an individual entitlement that each can take regardless of the other.


Length of paid parental leave for mother (calendar days)

The indicator refers to days of parental leave reserved specifically for mothers—through “use-it-or-lose-it” policies or mothers’ quotas; or days of parental leave that employees are individually entitled to.


Length of paid parental leave for father (calendar days)

The indicator refers to days of parental leave reserved specifically for fathers—that is, through “use-it-or-lose-it” policies or fathers’ quotas; or days of parental leave that employees are individually entitled to.


Number of Polindes (Poliklinik Desa/Village Polyclinic)


Prevalence of anemia among pregnant women (%)

Prevalence of anemia, pregnant women, is the percentage of pregnant women whose hemoglobin level is less than 110 grams per liter at sea level.

World Health Organization, Global Health Observatory Data Repository/World Health Statistics.


Prevalence of syphilis (% of women attending antenatal care)

Percentage of women attending antenatal care seropositive for syphilis


Prevalence of current tobacco use (% of adults)

The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.

World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).


Prevalence of current tobacco use, females (% of female adults)

The percentage of the female population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.


Smoking (% of women): Q1 (lowest)

Smoking: Percentage of all women who smoke cigarettes, pipe or other tobacco.


Prevalence of current tobacco use, males (% of male adults)

The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.


Length of paid paternity leave (calendar days)

The indicator refers to leave available only to the father for the birth of a child.


Paid leave is available to fathers (1=yes; 0=no)

The indicator measures whether fathers are legally entitled to at least one day of paid leave for the birth of a child, or if the law reserves a portion of paid parental leave specifically for fathers—that is, through “use-it-or-lose-it” policies or fathers’ quotas; or if fathers are individually entitled to paid parental leave.


Number of Puskesmas and its line services

BADAN PUSAT STATISTIK - Statistics Indonesia, Village Census (PODES)


Risk of catastrophic expenditure for surgical care (% of people at risk)

The proportion of population at risk of catastrophic expenditure when surgical care is required. Catastrophic expenditure is defined as direct out of pocket payments for surgical and anaesthesia care exceeding 10% of total income.

The Program in Global Surgery and Social Change (PGSSC) at Harvard Medical School (https://www.pgssc.org/)


Risk of impoverishing expenditure for surgical care (% of people at risk)

The proportion of population at risk of impoverishing expenditure when surgical care is required. Impoverishing expenditure is defined as direct out of pocket payments for surgical and anaesthesia care which drive people below a poverty threshold (using a threshold of $2.15 PPP/day).


Number of surgical procedures (per 100,000 population)

The number of procedures undertaken in an operating theatre per 100,000 population per year in each country. A procedure is defined as the incision, excision, or manipulation of tissue that needs regional or general anaesthesia, or profound sedation to control pain.

Data from various sources compiled by the Lancet Commission on Global Surgery (www.lancetglobalsurgery.org) and the Center for Health Equity in Surgery and Anesthesia at UCSF Medical Center.


Health care (% of population with access)


Improved sanitation facilities (% of population with access)

Access to improved sanitation facilities refers to the percentage of the population using improved sanitation facilities. Improved sanitation facilities are likely to ensure hygienic separation of human excreta from human contact. They include flush/pour flush (to piped sewer system, septic tank, pit latrine), ventilated improved pit (VIP) latrine, pit latrine with slab, and composting toilet.

WHO/UNICEF Joint Monitoring Programme (JMP) for Water Supply and Sanitation (http://www.wssinfo.org/).


Improved sanitation facilities, rural (% of rural population with access)

Access to improved sanitation facilities, rural, refers to the percentage of the rural population using improved sanitation facilities. Improved sanitation facilities are likely to ensure hygienic separation of human excreta from human contact. They include flush/pour flush (to piped sewer system, septic tank, pit latrine), ventilated improved pit (VIP) latrine, pit latrine with slab, and composting toilet.


Improved sanitation facilities, urban (% of urban population with access)

Access to improved sanitation facilities, urban, refers to the percentage of the urban population using improved sanitation facilities. Improved sanitation facilities are likely to ensure hygienic separation of human excreta from human contact. They include flush/pour flush (to piped sewer system, septic tank, pit latrine), ventilated improved pit (VIP) latrine, pit latrine with slab, and composting toilet.


Mortality rate attributed to household and ambient air pollution, age-standardized, female (per 100,000 female population)

Mortality rate attributed to household and ambient air pollution is the number of deaths attributable to the joint effects of household and ambient air pollution in a year per 100,000 population. The rates are age-standardized.  Following diseases are taken into account: acute respiratory infections (estimated for all ages); cerebrovascular diseases in adults (estimated above 25 years); ischaemic heart diseases in adults (estimated above 25 years); chronic obstructive pulmonary disease in adults (estimated above 25 years); and lung cancer in adults (estimated above 25 years).


Mortality rate attributed to household and ambient air pollution, age-standardized, male (per 100,000 male population)


Mortality rate attributed to household and ambient air pollution, age-standardized (per 100,000 population)


Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q1 (lowest)

Components of antenatal care: Percentage of women with a live birth in the three years preceding the survey who received iron tablets or syrup during pregnancy before the most recent birth.


Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q2


Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q3


Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q4


Components of antenatal care (received iron tablets or syrup) (% of women with a birth): Q5 (highest)


Pregnant women receiving prenatal care of at least four visits (% of pregnant women)

Pregnant women receiving prenatal care, at least four times, are the percentage of women attended at least four times during pregnancy by skilled health personnel for reasons related to pregnancy.


Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)

Antenatal care: Percentage of women with one or more live births in the three (one, two) years preceding the survey who have received at least one antenatal care during pregnancy before the most recent birth from any skilled personnel and from a doctor. If the respondent mentioned more than one provider, only the most qualified provider is considered. The DHS surveys refer births in the three years preceding the survey, the MICS2 surveys refer births in the one year preceding the survey, and the MICS3 surveys refer births in the two years preceding the survey.


Antenatal care (any skilled personnel) (% of women with a birth): Q2


Antenatal care (any skilled personnel) (% of women with a birth): Q3


Antenatal care (any skilled personnel) (% of women with a birth): Q4


Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)


Pregnant women receiving prenatal care (%)

Pregnant women receiving prenatal care are the percentage of women attended at least once during pregnancy by skilled health personnel for reasons related to pregnancy.


Antenatal care (doctor) (% of women with a birth): Q1 (lowest)


Antenatal care (doctor) (% of women with a birth): Q2


Antenatal care (doctor) (% of women with a birth): Q3


Antenatal care (doctor) (% of women with a birth): Q4


Antenatal care (doctor) (% of women with a birth): Q5 (highest)


Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)

Treatment of acute respiratory infection (ARI): Percentage of children under age five years with acute respiratory infection (ARI) in the two weeks preceding the survey who were taken to a health facility.


Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2


Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3


Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4


Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)


ARI treatment (% of children under 5 taken to a health provider)

Children with acute respiratory infection (ARI) who are taken to a health provider refers to the percentage of children under age five with ARI in the last two weeks who were taken to an appropriate health provider, including hospital, health center, dispensary, village health worker, clinic, and private physician.


Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)

Prevalence of acute respiratory infection (ARI): Percentage of children under age five years who were ill with a cough accompanied with rapid breathing in the two weeks preceding the survey.


Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2


Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3


Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4


Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)


ARI prevalence (% of children under 5)

Children with acute respiratory infection (ARI) refers to the percentage of children under age five with ARI in the last two weeks.


People using at least basic sanitation services (% of population): Q1 (lowest)

WHO/UNICEF Joint Monitoring Programme (JMP) for Water Supply, Sanitation and Hygiene (washdata.org).


People using at least basic sanitation services (% of population): Q2


People using at least basic sanitation services (% of population): Q3


People using at least basic sanitation services (% of population): Q4


People using at least basic sanitation services (% of population): Q5 (highest)


People using at least basic sanitation services, rural (% of rural population): Q1 (lowest)


People using at least basic sanitation services, rural (% of rural population): Q2


People using at least basic sanitation services, rural (% of rural population): Q3


People using at least basic sanitation services, rural (% of rural population): Q4


People using at least basic sanitation services, rural (% of rural population): Q5 (highest)


People using at least basic sanitation services, rural (% of rural population)

The percentage of people using at least basic sanitation services, that is, improved sanitation facilities that are not shared with other households.  This indicator encompasses both people using basic sanitation services as well as those using safely managed sanitation services.   Improved sanitation facilities include flush/pour flush to piped sewer systems, septic tanks or pit latrines; ventilated improved pit latrines, compositing toilets or pit latrines with slabs.


People using at least basic sanitation services, urban  (% of urban population): Q1 (lowest)


People using at least basic sanitation services, urban  (% of urban population): Q2


People using at least basic sanitation services, urban  (% of urban population): Q3


People using at least basic sanitation services, urban  (% of urban population): Q4


People using at least basic sanitation services, urban  (% of urban population): Q5 (highest)


People using at least basic sanitation services, urban (% of urban population)


People using at least basic sanitation services (% of population)


Breastfeeding (% of children under 6 months): Q1 (lowest)

Breastfeeding: The percentage of children under age 6 months who were breastfed six or more times in the 24 hours preceding the interview.


Breastfeeding (% of children under 6 months): Q2


Breastfeeding (% of children under 6 months): Q3


Breastfeeding (% of children under 6 months): Q4


Breastfeeding (% of children under 6 months): Q5 (highest)


Exclusive breastfeeding (% of children under 6 months)

Exclusive breastfeeding refers to the percentage of children less than six months old who are fed breast milk alone (no other liquids) in the past 24 hours.


Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)

Assistance during delivery (Assisted births): Percentage of live births in the three (one, two) years preceding the survey attended by any skilled personnel and by a doctor.  The DHS surveys refer births in the three years preceding the survey, the MICS2 surveys refer births in the one year preceding the survey, and the MICS3 surveys refer births in the two years preceding the survey.


Assistance during delivery (any skilled personnel) (% of births): Q2


Assistance during delivery (any skilled personnel) (% of births): Q3


Assistance during delivery (any skilled personnel) (% of births): Q4


Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)


Births attended by skilled health staff (% of total)

Births attended by skilled health staff are the percentage of deliveries attended by personnel trained to give the necessary supervision, care, and advice to women during pregnancy, labor, and the postpartum period; to conduct deliveries on their own; and to care for newborns.


Place of delivery (births at health facility) (% of births): Q1 (lowest)

Place of delivery (Births at health facility): Percentage of live births in the three years preceding the survey which took place at health facility.


Place of delivery (births at health facility) (% of births): Q2


Place of delivery (births at health facility) (% of births): Q3


Place of delivery (births at health facility) (% of births): Q4


Place of delivery (births at health facility) (% of births): Q5 (highest)


Assistance during delivery (doctor) (% of births): Q1 (lowest)


Assistance during delivery (doctor) (% of births): Q2


Assistance during delivery (doctor) (% of births): Q3


Assistance during delivery (doctor) (% of births): Q4


Assistance during delivery (doctor) (% of births): Q5 (highest)


Low-birthweight babies (% of births)

Low-birthweight babies are newborns weighing less than 2,500 grams, with the measurement taken within the first hour of life, before significant postnatal weight loss has occurred.

UNICEF-WHO Low birthweight estimates [data.unicef.org]


Diabetes prevalence (% of population ages 20 to 79)

Diabetes prevalence refers to the percentage of people ages 20-79 who have type 1 or type 2 diabetes. It is calculated by adjusting to a standard population age-structure.

International Diabetes Federation, Diabetes Atlas.


Prevalence of diarrhea (% of children under 5): Q1 (lowest)

Prevalence of diarrhea: Percentage of children under age five years who had diarrhea in the two weeks preceding the survey.


Prevalence of diarrhea (% of children under 5): Q2


Prevalence of diarrhea (% of children under 5): Q3


Prevalence of diarrhea (% of children under 5): Q4


Prevalence of diarrhea (% of children under 5): Q5 (highest)


Diarrhea prevalence (% of children under 5)

Diarrhea prevalence is the percentage of children under age five who had diarrhea in the two weeks prior to the survey.

United Nations Children's Fund, Demographic and Health Surveys, and Multiple Indicator Cluster Surveys.


Prevalence of children with fever (% of children under 5): Q1 (lowest)

Prevalence of children with fever: Percentage of children under age five years with fever in the two weeks preceding the survey.


Prevalence of children with fever (% of children under 5): Q2


Prevalence of children with fever (% of children under 5): Q3


Prevalence of children with fever (% of children under 5): Q4


Prevalence of children with fever (% of children under 5): Q5 (highest)


Women who believe that female genital mutilation should not be continued (% of women ages 15-49 who have heard about FGM)

Percentage of women ages 15-49 who have heard about female genital mutilation and think the practice should end.

UNICEF DATA (http://www.data.unicef.org/);  Demographic and Health Surveys (DHS); Multiple Indicator Cluster Surveys (MICS), and other surveys.


Men who believe that female genital mutilation should not be continued (% of men who have heard about FGM)

Percentage of men who have heard about female genital mutilation and think the practice should end.


Women who believe religion requires female genital mutilation (% of women ages 15-49 who have heard about FGM)

Percentage of women ages 15-49 who have heard about female genital mutilation (FGM) and whose opinion is that religion requires FGM.


Men who believe religion requires female genital mutilation  (% of men who have heard about FGM)

Percentage of men who have heard about female genital mutilation (FGM) and whose opinion is that religion requires FGM.


Female genital mutilation prevalence (%): Q1 (lowest)

Percentage of women aged 15–49 who have gone through partial or total removal of the female external genitalia or other injury to the female genital organs for cultural or other non-therapeutic reasons. Each wealth quintile represents one fifth of households with quintile 1 being the poorest 20 percent of households and quintile 5 being the richest 20 percent of households.


Female genital mutilation prevalence (%): Q2


Female genital mutilation prevalence (%): Q3


Female genital mutilation prevalence (%): Q4


Female genital mutilation prevalence (%): Q5 (highest)


Female genital mutilation prevalence (%)

Percentage of women aged 15–49 who have gone through partial or total removal of the female external genitalia or other injury to the female genital organs for cultural or other non-therapeutic reasons.


People with basic handwashing facilities including soap and water (% of population): Q1 (lowest)

The percentage of people living in households that have a handwashing facility with soap and water available on the premises. Handwashing facilities may be fixed or mobile and include a sink with tap water, buckets with taps, tippy-taps, and jugs or basins designated for handwashing. Soap includes bar soap, liquid soap, powder detergent, and soapy water but does not include ash, soil, sand or other handwashing agents.


People with basic handwashing facilities including soap and water (% of population): Q2


People with basic handwashing facilities including soap and water (% of population): Q3


People with basic handwashing facilities including soap and water (% of population): Q4


People with basic handwashing facilities including soap and water (% of population): Q5 (highest)


People with basic handwashing facilities including soap and water, rural (% of rural population): Q1 (lowest)


People with basic handwashing facilities including soap and water, rural (% of rural population): Q2


People with basic handwashing facilities including soap and water, rural (% of rural population): Q3


People with basic handwashing facilities including soap and water, rural (% of rural population): Q4


People with basic handwashing facilities including soap and water, rural (% of rural population): Q5 (highest)


People with basic handwashing facilities including soap and water, rural (% of rural population)


People with basic handwashing facilities including soap and water, urban (% of urban population): Q1 (lowest)


People with basic handwashing facilities including soap and water, urban (% of urban population): Q2


People with basic handwashing facilities including soap and water, urban (% of urban population): Q3


People with basic handwashing facilities including soap and water, urban (% of urban population): Q4


People with basic handwashing facilities including soap and water, urban (% of urban population): Q5 (highest)


People with basic handwashing facilities including soap and water, urban (% of urban population)


People with basic handwashing facilities including soap and water (% of population)


Infant and young child feeding practices, all 3 IYCF (% children ages 6-23 months)

Percentage of children age 6-23 months fed in accordance with all three infant and young child feeding (IYCF) practices (food diversity, feeding frequency, and consumption of breast milk or milk)


Malnourished women (BMI is less than 18.5) (% of women): Q1 (lowest)

Malnourished women (BMI is less than 18.5): Percentage of women whose body mass index (BMI) is less than 18.5 for women with births in the three years preceding the survey. The BMI is the ratio of the weight in kilograms to the square of the height in meters (kg/m2). The BMI excludes pregnant women and those who are less than three months postpartum.


Malnourished women (BMI is less than 18.5) (% of women): Q2


Malnourished women (BMI is less than 18.5) (% of women): Q3


Malnourished women (BMI is less than 18.5) (% of women): Q4


Malnourished women (BMI is less than 18.5) (% of women): Q5 (highest)


Prevalence of underweight, weight for age, female (% of children under 5)

Prevalence of underweight, female, is the percentage of girls under age 5 whose weight for age is more than two standard deviations below the median for the international reference population ages 0-59 months. The data are based on the WHO's 2006 Child Growth Standards.

UNICEF, WHO, World Bank: Joint child Malnutrition Estimates (JME). Aggregation is based on UNICEF, WHO, and the World Bank harmonized dataset (adjusted, comparable data) and methodology.


Prevalence of underweight, weight for age, male (% of children under 5)

Prevalence of underweight, male, is the percentage of boys under age 5 whose weight for age is more than two standard deviations below the median for the international reference population ages 0-59 months. The data are based on the WHO's 2006 Child Growth Standards.


Malnourished children (underweight, -2SD) (% of children under 5): Q1 (lowest)

Malnourished children: Percentage of children under age five years who are classified as undernourished according to three anthropometric indices of nutritional status: height-for-age (stunting), weight-for-age (underweight) and weight-for-height (wasting). Each index is expressed in terms of the number of standard deviation (SD) units from the median of the WHO Child Growth Standards. Children are classified as malnourished if their z-scores are below minus two or minus three standard deviations (-2 SD or -3 SD) from the median of the WHO Child Growth Standards. The percentage below -2 SD includes children who are below -3 SD.


Malnourished children (underweight, -2SD) (% of children under 5): Q2


Malnourished children (underweight, -2SD) (% of children under 5): Q3


Malnourished children (underweight, -2SD) (% of children under 5): Q4


Malnourished children (underweight, -2SD) (% of children under 5): Q5 (highest)


Prevalence of underweight, weight for age (% of children under 5)

Prevalence of underweight children is the percentage of children under age 5 whose weight for age is more than two standard deviations below the median for the international reference population ages 0-59 months. The data are based on the WHO's 2006 Child Growth Standards.


Malaria cases reported

Reported cases of malaria are the number of confirmed cases of malaria (confirmed by slide examination or RDT).

World Health Organization, Global Health Observatory Data Repository/World Health Statistics (http://apps.who.int/ghodata/). WHO compiles data on reported cases of malaria, submitted by the national malaria control programmes (NMCPs).


Malnourished children (underweight, -3SD) (% of children under 5): Q1 (lowest)


Malnourished children (underweight, -3SD) (% of children under 5): Q2


Malnourished children (underweight, -3SD) (% of children under 5): Q3


Malnourished children (underweight, -3SD) (% of children under 5): Q4


Malnourished children (underweight, -3SD) (% of children under 5): Q5 (highest)


Maternal mortality ratio (modeled estimate, per 100,000 live births)

Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births. The data are estimated with a regression model using information on the proportion of maternal deaths among non-AIDS deaths in women ages 15-49, fertility, birth attendants, and GDP measured using purchasing power parities (PPPs).


Maternal mortality ratio (national estimate, per 100,000 live births)

Maternal mortality ratio is the number of women who die from pregnancy-related causes while pregnant or within 42 days of pregnancy termination per 100,000 live births.

The country data compiled, adjusted and used in the estimation model by the Maternal Mortality Estimation Inter-Agency Group (MMEIG). The country data were compiled from the following sources:  civil registration and vital statistics; specialized studies on maternal mortality; population based surveys and censuses; other available data sources including data from surveillance sites.


Prevalence of obesity, female (% of female population ages 18+)

Prevalence of obesity adult is the percentage of adults ages 18 and over whose Body Mass Index (BMI) is 30 kg/m² or higher. Body Mass Index (BMI) is a simple index of weight-for-height, or the weight in kilograms divided by the square of the height in meters.

World Health Organization (WHO):Global Health Observatory Data Repository


Prevalence of obesity, male (% of male population ages 18+)

World Health Organization (WHO): Global Health Observatory Data Repository


People practicing open defecation (% of population): Q1 (lowest)


People practicing open defecation (% of population): Q2


People practicing open defecation (% of population): Q3


People practicing open defecation (% of population): Q4


People practicing open defecation (% of population): Q5 (highest)


People practicing open defecation, rural (% of rural population): Q1 (lowest)


People practicing open defecation, rural (% of rural population): Q2


People practicing open defecation, rural (% of rural population): Q3


People practicing open defecation, rural (% of rural population): Q4


People practicing open defecation, rural (% of rural population): Q5 (highest)


People practicing open defecation, rural (% of rural population)

People practicing open defecation refers to the percentage of the population defecating in the open, such as in fields, forest, bushes, open bodies of water, on beaches, in other open spaces or disposed of with solid waste.


People practicing open defecation, urban (% of urban population): Q1 (lowest)


People practicing open defecation, urban (% of urban population): Q2


People practicing open defecation, urban (% of urban population): Q3


People practicing open defecation, urban (% of urban population): Q4


People practicing open defecation, urban (% of urban population): Q5 (highest)


People practicing open defecation, urban (% of urban population)


People practicing open defecation (% of population)


Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)

Children with diarrhea who received oral rehydration and continued feeding refer to the percentage of children under age five with diarrhea in the two weeks prior to the survey who received either oral rehydration therapy or increased fluids, with continued feeding.

UNICEF, State of the World's Children, Childinfo, and Demographic and Health Surveys.


Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q1 (lowest)

Treatment of diarrhea (ORS, RHS or increased fluids): Percentage of children under age five years with diarrhea in the two weeks preceding the survey who received oral rehydration solution (ORS), recommended home solution (RHS) or increased fluids.


Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q2


Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q3


Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q4


Treatment of diarrhea (ORS, RHS or increased fluids) (% of children under 5): Q5 (highest)


Knowledge of diarrhea care (% of mothers): Q1 (lowest)

Knowledge of diarrhea care: Percentage of mothers with births in the three years preceding the survey who know about oral rehydration salts (ORS) packets.


Knowledge of diarrhea care (% of mothers): Q2


Knowledge of diarrhea care (% of mothers): Q3


Knowledge of diarrhea care (% of mothers): Q4


Knowledge of diarrhea care (% of mothers): Q5 (highest)


Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q1 (lowest)

Treatment of diarrhea (either ORS or RHS): Percentage of children under age five years with diarrhea in the two weeks preceding the survey who received either oral rehydration solution (ORS) or recommended home solution (RHS).


Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q2


Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q3


Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q4


Treatment of diarrhea (either ORS or RHS) (% of children under 5): Q5 (highest)


Diarrhea treatment (% of children under 5 who received ORS packet)

Percentage of children under age 5 with diarrhea in the two weeks preceding the survey who received oral rehydration salts (ORS packets or pre-packaged ORS fluids).


Prevalence of overweight, female (% of female adults)

Prevalence of overweight female adults is the percentage of females ages 18 and over whose Body Mass Index (BMI) is more than 25 kg/m2. Body Mass Index (BMI) is a simple index of weight-for-height, or the weight in kilograms divided by the square of the height in meters.


Prevalence of overweight, male (% of male adults)

Prevalence of overweight male adults is the percentage of males ages 18 and over whose Body Mass Index (BMI) is more than 25 kg/m2. Body Mass Index (BMI) is a simple index of weight-for-height, or the weight in kilograms divided by the square of the height in meters.


Prevalence of overweight (% of adults)

Prevalence of overweight adults is the percentage of adults ages 18 and over whose Body Mass Index (BMI) is more than 25 kg/m2. Body Mass Index (BMI) is a simple index of weight-for-height, or the weight in kilograms divided by the square of the height in meters.


Prevalence of overweight, weight for height, female (% of children under 5)

Prevalence of overweight, female, is the percentage of girls under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's 2006 Child Growth Standards.


Prevalence of overweight, weight for height, male (% of children under 5)

Prevalence of overweight, male, is the percentage of boys under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's 2006 Child Growth Standards.


Prevalence of overweight (modeled estimate, % of children under 5)

Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's 2006 Child Growth Standards.

UNICEF, WHO, World Bank: Joint child Malnutrition Estimates (JME).


Prevalence of overweight, weight for height (% of children under 5)


Postnatal care coverage (% mothers)

Percentage of women with a postnatal checkup in the first two days after birth


Mortality rate attributed to unintentional poisoning (per 100,000 population)

Mortality rate attributed to unintentional poisonings is the number of deaths from unintentional poisonings in a year per 100,000 population.  Unintentional poisoning can
be caused by household chemicals, pesticides, kerosene, carbon monoxide and medicines, or can be the result of environmental contamination or occupational chemical exposure.

World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).


Mortality rate attributed to unintentional poisoning, female (per 100,000 female population)

Mortality rate attributed to unintentional poisonings is the number of female deaths from unintentional poisonings in a year per 100,000 female population.  Unintentional poisoning can be caused by household chemicals, pesticides, kerosene, carbon monoxide and medicines, or can be the result of environmental contamination or occupational chemical exposure.


Mortality rate attributed to unintentional poisoning, male (per 100,000 male population)

Mortality rate attributed to unintentional poisonings is the number of male deaths from unintentional poisonings in a year per 100,000 male population. Unintentional poisoning can
be caused by household chemicals, pesticides, kerosene, carbon monoxide and medicines, or can be the result of environmental contamination or occupational chemical exposure.


People using safely managed sanitation services, rural (% of rural population)

The percentage of people using improved sanitation facilities that are not shared with other households and where excreta are safely disposed of in situ or transported and treated offsite. Improved sanitation facilities include flush/pour flush to piped sewer systems, septic tanks or pit latrines: ventilated improved pit latrines, compositing toilets or pit latrines with slabs.


People using safely managed sanitation services, urban (% of urban population)


People using safely managed sanitation services (% of population)


Malnourished children (stunting, -3SD) (% of children under 5): Q1 (lowest)

Malnourished children: Percentage of children under age five years who are classified as undernourished according to three anthropometric indices of nutritional status: height-for-age (stunting), weight-for-age (underweight) and weight-for-height (wasting). Each index is expressed in terms of the number of standard deviation (SD) units from the median of the WHO Child Growth Standards. Children are classified as malnourished if their z-scores are below minus two or minus three standard deviations (-2 SD or -3 SD) from the median of the WHO Child Growth Standards. The percentage below -2 SD includes children who are below -3 SD.


Malnourished children (stunting, -3SD) (% of children under 5): Q2


Malnourished children (stunting, -3SD) (% of children under 5): Q3


Malnourished children (stunting, -3SD) (% of children under 5): Q4


Malnourished children (stunting, -3SD) (% of children under 5): Q5 (highest)


Prevalence of stunting, height for age, female (% of children under 5)

Prevalence of stunting, female, is the percentage of girls under age 5 whose height for age is more than two standard deviations below the median for the international reference population ages 0-59 months. For children up to two years old height is measured by recumbent length. For older children height is measured by stature while standing. The data are based on the WHO's 2006 Child Growth Standards.


Prevalence of stunting, height for age, male (% of children under 5)

Prevalence of stunting, male, is the percentage of boys under age 5 whose height for age is more than two standard deviations below the median for the international reference population ages 0-59 months. For children up to two years old height is measured by recumbent length. For older children height is measured by stature while standing. The data are based on the WHO's 2006 Child Growth Standards.


Prevalence of stunting, height for age (modeled estimate, % of children under 5)

Prevalence of stunting is the percentage of children under age 5 whose height for age is more than two standard deviations below the median for the international reference population ages 0-59 months. For children up to two years old height is measured by recumbent length. For older children height is measured by stature while standing. The data are based on the WHO's 2006 Child Growth Standards.


Malnourished children (stunting, -2SD) (% of children under 5): Q1 (lowest)


Malnourished children (stunting, -2SD) (% of children under 5): Q2


Malnourished children (stunting, -2SD) (% of children under 5): Q3


Malnourished children (stunting, -2SD) (% of children under 5): Q4


Malnourished children (stunting, -2SD) (% of children under 5): Q5 (highest)


Prevalence of stunting, height for age (% of children under 5)


Suicide mortality rate, female (per 100,000 female population)

Suicide mortality rate is the number of suicide deaths in a year per 100,000 population. Crude suicide rate (not age-adjusted).


Suicide mortality rate, male (per 100,000 male population)


Suicide mortality rate (per 100,000 population)


Mortality caused by road traffic injury, female (per 100,000 female population)

Mortality caused by road traffic injury is estimated road traffic fatal injury deaths per 100,000 population.


Mortality caused by road traffic injury, male (per 100,000 male population)


Mortality caused by road traffic injury (per 100,000 population)


Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, female (per 100,000 female population)

Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene is deaths attributable to unsafe water, sanitation and hygiene focusing on inadequate WASH services per 100,000 population. Death rates are calculated by dividing the number of deaths by the total population. In this estimate, only the impact of diarrhoeal diseases, intestinal nematode infections, and protein-energy malnutrition are taken into account.


Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene, male (per 100,000 male population)


Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (per 100,000 population)


Prevalence of wasting, weight for height, female (% of children under 5)

Prevalence of wasting, female, is the proportion of girls under age 5 whose weight for height is more than two standard deviations below the median for the international reference population ages 0-59 months.


Prevalence of wasting, weight for height, male (% of children under 5)

Prevalence of wasting, male, is the proportion of boys under age 5 whose weight for height is more than two standard deviations below the median for the international reference population ages 0-59 months.


Malnourished children (wasting, -2SD) (% of children under 5): Q1 (lowest)


Malnourished children (wasting, -2SD) (% of children under 5): Q2


Malnourished children (wasting, -2SD) (% of children under 5): Q3


Malnourished children (wasting, -2SD) (% of children under 5): Q4


Malnourished children (wasting, -2SD) (% of children under 5): Q5 (highest)


Prevalence of wasting, weight for height (% of children under 5)

Prevalence of wasting is the proportion of children under age 5 whose weight for height is more than two standard deviations below the median for the international reference population ages 0-59 months.


Malnourished children (wasting, -3SD) (% of children under 5): Q1 (lowest)


Malnourished children (wasting, -3SD) (% of children under 5): Q2


Malnourished children (wasting, -3SD) (% of children under 5): Q3


Malnourished children (wasting, -3SD) (% of children under 5): Q4


Malnourished children (wasting, -3SD) (% of children under 5): Q5 (highest)


Prevalence of severe wasting, weight for height, female (% of children under 5)

Prevalence of severe wasting, female, is the proportion of girls under age 5 whose weight for height is more than three standard deviations below the median for the international reference population ages 0-59 months.


Prevalence of severe wasting, weight for height, male (% of children under 5)

Prevalence of severe wasting, male, is the proportion of boys under age 5 whose weight for height is more than three standard deviations below the median for the international reference population ages 0-59 months.


Prevalence of severe wasting, weight for height (% of children under 5)

Prevalence of severe wasting is the proportion of children under age 5 whose weight for height is more than three standard deviations below the median for the international reference population ages 0-59 months.


Tuberculosis treatment success rate (% of new cases)

Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).

World Health Organization, Global Tuberculosis Report.


Tuberculosis cases detected under DOTS (%)

DOTS detection rate is the percentage of estimated new infectious tuberculosis cases detected under the directly observed treatment, short course case detection and treatment strategy.

World Health Organization, Global Tuberculosis Control Report.


Tuberculosis case detection rate (%, all forms)

Tuberculosis case detection rate (all forms) is the number of new and relapse tuberculosis cases notified to WHO in a given year, divided by WHO's estimate of the number of incident tuberculosis cases for the same year, expressed as a percentage. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.


Incidence of tuberculosis (per 100,000 people)

Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.


Incidence of tuberculosis, high uncertainty bound (per 100,000 people)

Incidence of tuberculosis is the estimated number of new pulmonary, smear positive, and extra-pulmonary tuberculosis cases.


Incidence of tuberculosis, low uncertainty bound (per 100,000 people)


Tuberculosis death rate (per 100,000 people)

Tuberculosis death rate is the estimated number of deaths from tuberculosis among HIV-negative people, expressed as the rate per 100,000 population. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.


Deaths due to tuberculosis among HIV-negative people, high uncertainty bound (per 100,000 population)

The estimated number of deaths attributable to tuberculosis (TB) in a given time period.


Deaths due to tuberculosis among HIV-negative people, low uncertainty bound (per 100,000 population)


Tuberculosis prevalence rate (per 1000,000 population, WHO)

The number of cases of tuberculosis (all forms) in a population at a given point in time (the middle of the calendar year), expressed as the rate per 100 000 population. It is sometimes referred to as "point prevalence". Estimates include cases of TB in people with HIV. Published values are rounded to three significant figures. Uncertainty bounds are provided in addition to best estimates.


Tuberculosis prevalence rate, high uncertainty bound (per 1000,000 population, WHO)

The number of cases of tuberculosis (all forms) in a population at a given point in time (the middle of the calendar year), expressed as the rate per 100 000 population. It is sometimes referred to as "point prevalence" high uncertainty bound. Estimates include cases of TB in people with HIV.  Published values are rounded to three significant figures. Uncertainty bounds are provided in addition to best estimates.


Tuberculosis prevalence rate, low uncertainty bound (per 1000,000 population, WHO)

The number of cases of tuberculosis (all forms) in a population at a given point in time (the middle of the calendar year), expressed as the rate per 100 000 population. It is sometimes referred to as "point prevalence" low uncertainty bound. Estimates include cases of TB in people with HIV.  Published values are rounded to three significant figures. Uncertainty bounds are provided in addition to best estimates.


Number of people pushed below the 50% median consumption poverty line by out-of-pocket health care expenditure

Wagstaff et al. Progress on Impoverishing Health Spending: Results for 122 Countries. A Retrospective Observational Study, Lancet Global Health 2017.


Proportion of population pushed below the 50% median consumption poverty line by out-of-pocket health care expenditure (%)

Proportion of population pushed below the 50% median consumption poverty line by out-of-pocket health care expenditure, expressed as a percentage of a total population of a country


Number of people pushed further below the $2.15 ($ 2017 PPP) poverty line by out-of-pocket health care expenditure

This indicator shows the number of people living in households whose non-health expenditures are already below the $2.15 poverty line and who as a result are pushed further into poverty by their out-of-pocket health spending. Out-of-pocket health expenditure is defined as any spending incurred by a household when any member uses a health good or service to receive any type of care (preventive, curative, rehabilitative, long-term or palliative care); provided by any type of provider; for any type of disease, illness or health condition; in any type of setting (outpatient, inpatient, at home).

Global Health Observatory. Geneva: World Health Organization; 2023. (https://www.who.int/data/gho/data/themes/topics/financial-protection)


Proportion of population pushed further below the $2.15 ($ 2017 PPP) poverty line by out-of-pocket health care expenditure (%)

This indicator shows the fraction of a country’s population living in households whose non-health expenditures are already below the $2.15 poverty line and who as a result are pushed further into poverty by their out-of-pocket health spending. Out-of-pocket health expenditure is defined as any spending incurred by a household when any member uses a health good or service to receive any type of care (preventive, curative, rehabilitative, long-term or palliative care); provided by any type of provider; for any type of disease, illness or health condition; in any type of setting (outpatient, inpatient, at home).


Number of people pushed further below the $3.65 ($ 2017 PPP) poverty line by out-of-pocket health care expenditure

This indicator shows the number of people living in households whose non-health expenditures are already below the $3.65 poverty line and who as a result are pushed further into poverty by their out-of-pocket health spending.  Out-of-pocket health expenditure is defined as any spending incurred by a household when any member uses a health good or service to receive any type of care (preventive, curative, rehabilitative, long-term or palliative care); provided by any type of provider; for any type of disease, illness or health condition; in any type of setting (outpatient, inpatient, at home).